Clinical Trials Browser

Phase 2 × Neoadjuvant Therapy × Poly(ADP-ribose) Polymerase Inhibitors × Clear all

NCT05406999 2022-08-16

Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer

Phase 2 Recruiting

Neoadjuvant Therapy